Emergent BioSolutions Inc (EBS)
9.48
+0.08
(+0.85%)
USD |
NYSE |
Nov 22, 16:00
9.41
-0.07
(-0.74%)
After-Hours: 19:37
Emergent BioSolutions Shareholders Equity (Quarterly): 508.40M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 508.40M |
June 30, 2024 | 386.30M |
March 31, 2024 | 663.90M |
December 31, 2023 | 649.30M |
September 30, 2023 | 697.20M |
June 30, 2023 | 956.30M |
March 31, 2023 | 1.203B |
December 31, 2022 | 1.388B |
September 30, 2022 | 1.449B |
June 30, 2022 | 1.513B |
March 31, 2022 | 1.575B |
December 31, 2021 | 1.612B |
September 30, 2021 | 1.523B |
June 30, 2021 | 1.544B |
March 31, 2021 | 1.523B |
December 31, 2020 | 1.447B |
September 30, 2020 | 1.252B |
June 30, 2020 | 1.199B |
March 31, 2020 | 1.075B |
December 31, 2019 | 1.088B |
September 30, 2019 | 1.035B |
June 30, 2019 | 988.90M |
March 31, 2019 | 987.50M |
December 31, 2018 | 1.011B |
September 30, 2018 | 966.65M |
Date | Value |
---|---|
June 30, 2018 | 938.35M |
March 31, 2018 | 881.28M |
December 31, 2017 | 912.30M |
September 30, 2017 | 663.71M |
June 30, 2017 | 620.60M |
March 31, 2017 | 610.42M |
December 31, 2016 | 596.20M |
September 30, 2016 | 547.62M |
June 30, 2016 | 672.67M |
March 31, 2016 | 666.98M |
December 31, 2015 | 660.02M |
September 30, 2015 | 605.31M |
June 30, 2015 | 562.25M |
March 31, 2015 | 537.88M |
December 31, 2014 | 553.20M |
September 30, 2014 | 513.14M |
June 30, 2014 | 487.77M |
March 31, 2014 | 477.50M |
December 31, 2013 | 489.62M |
September 30, 2013 | 467.31M |
June 30, 2013 | 449.53M |
March 31, 2013 | 435.59M |
December 31, 2012 | 441.36M |
September 30, 2012 | 427.04M |
June 30, 2012 | 419.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
386.30M
Minimum
Jun 2024
1.612B
Maximum
Dec 2021
1.163B
Average
1.227B
Median
Shareholders Equity (Quarterly) Benchmarks
Geovax Labs Inc | 8.504M |
Tonix Pharmaceuticals Holding Corp | 74.21M |
Abbott Laboratories | 39.80B |
Insulet Corp | 1.118B |
SIGA Technologies Inc | 169.44M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.478B |
Total Liabilities (Quarterly) | 969.40M |
Debt to Equity Ratio | 1.303 |
Current Ratio | 2.877 |
Net Debt Paydown Yield | 10.66% |